Staphylococcal enterotoxin B (SEB) was tested in rodent mast cell cultures for the release of serotonin. Both rat RBL-2H3 mast cells and murine peritoneal cells released serotonin after SEB stimulation in culture. Release of serotonin in RBL-2H3 cells depended on the concentration of SEB; an appreciable release was seen at 50 ,ug/ml. The mechanism whereby staphylococcal enterotoxins cause toxic shock and other syndromes is unknown. Marrack and coworkers (32) suggested that the pathological reaction (weight loss and immunosuppression) in mice to staphylococcal enterotoxin B (SEB) is caused by T cells that are able to respond to SEB by mitosis. However, th6 toxicity of SEB and the related toxin staphylococcal enterotoxin C1 in monkeys is partially dissociated from the mitogellic effects of these molecules (45, 46) . Thus, cells other t1ii T cells may also be involved in SEB toxicosis. For examplde there is some indirect evidence that mast cells may also contribute to some of the toxic reactions to SEB. Scheuber and coworkers (41) intradermally injected SEB into monkeys and found an immediate-type skin reaction that was presumably caused by mast cells because it was inhibitable by histamine inhibitors.
The mechanism whereby staphylococcal enterotoxins cause toxic shock and other syndromes is unknown. Marrack and coworkers (32) suggested that the pathological reaction (weight loss and immunosuppression) in mice to staphylococcal enterotoxin B (SEB) is caused by T cells that are able to respond to SEB by mitosis. However, th6 toxicity of SEB and the related toxin staphylococcal enterotoxin C1 in monkeys is partially dissociated from the mitogellic effects of these molecules (45, 46) . Thus, cells other t1ii T cells may also be involved in SEB toxicosis. For examplde there is some indirect evidence that mast cells may also contribute to some of the toxic reactions to SEB. Scheuber and coworkers (41) intradermally injected SEB into monkeys and found an immediate-type skin reaction that was presumably caused by mast cells because it was inhibitable by histamine inhibitors.
We sought to study the interaction of mast cells with SEB. The RBL-2H3 rat leukemic cell line (3) and peritoneal mast cells from mice were used to determine whether SEB has a direct effect on mast cells. Most of the work was done with RBL-2H3 cells because of their homogeneity and the ease of obtaining large numbers of cells. In addition, there was no necessity to rule out immunoglobulin E-mediated phenomena (as there would be if fresh mast cells were used exclusively). We have found that rodent mast cells do in fact respond to SEB by releasing serotonin and that this response is enhanced by bradykinin. The SEB-binding site or receptor on mast cells appears to be a protein.
MATERIALS AND METHODS Materials. RBL-2H3 cells (3) were the kind gift of Reuben Siraganian, National Cancer Institute, Bethesda, Md. SEB was produced by the method of Schantz and coworkers (40) and was (34) , from which the RBL parent cell line was derived (25) .
Serotonin release assay. The serotonin release assay was conducted according to the method of Liu and coworkers (28) The 30-kDa band is intact SEB, while the smaller, 17-kDa band is presumably a proteolytic fragment. Most SEB preparations show some nicking, presumably as a result of enzymatic action or chemical hydrolysis either during fermentation or subsequent purification (47) . The pattern shown in Fig. 1 suggests that our SEB preparation was relatively pure.
Release of serotonin by RBL-2H3 mast cells. The RBL-2H3 mast cell line releases histamine and serotonin in response to antigen if the cells are coated with immunoglobulin E antibody to the antigen (3). The cells respond to several chemicals in the absence of immunoglobulin E, including A23187 and ionomycin (9), thapsigargin (a tumor promoter that releases cytoplasmic Ca + stores) (56), human neutrophilderived histamine-releasing activity (55) , and cobra venom cardiotoxin (29 (10) . SEB combined with possible enhancers, including bradykinin, lipopolysaccharide, substance P, and VIP was thus tested with RBL-2H3 cells. Table 1 shows that bradykinin was an enhancer of SEB-induced serotonin release from RBL-2H3 cells. VIP, substance P, A23187, acetylcholine, adenosine, HETE, indomethacin, lipopolysaccharide, concanavalin A, and phor- (Fig. 5A) . When the cells were treated with phycoerythrin-avidin alone (Fig.  SB) a Counts per minute are the means and standard errors of the means of four to six wells, except for bradykinin plus 100 ,ug of SEB, which was tested in two wells. The results were tested by Student's t test for the difference between two means (two tailed), with separate variances. The results with 100 and 200 ,ug of SEB are significantly different from the control result (P < 0.05 and P < 0.0001, respectively). The result for bradykinin alone is not significantly different from that for the control. The result for bradykinin plus 200 pg of SEB is significantly different from that for 200 pg of SEB alone (P < 0.0001). with N-glycanase, there was a slight change in the flow cytometry pattern, compared with untreated cells (Fig. 5C) . In contrast, when RBL-2H3 cells were treated with trypsin, the pattern changed significantly. The vast majority of cells became unstainable with SEB (Fig. 5D ). This result suggests that the binding site for SEB on mast cells is probably a protein.
To determine whether carbohydrates were involved in the SEB binding site, tunicamycin was used to inhibit N-linked glycosylation of the RBL-2H3 cells. The RBL-2H3 cells were then stained with biotinylated SEB and then by phycoerythrin-avidin. The result is shown in Fig. 6 . There was a slight reduction in the proportion of brightly staining cells in the treated group compared with in the vehicle control, but Although we did not identify the cells that release serotonin in our peritoneal cell preparations, it is likely that the serotonin-releasing cells were mast cells. In the body, serotonin is present, in addition to in mast cells, primarily in enterochromaffin cells (which are not likely to be present in large quantities in peritoneal washes) in the gastrointestinal tract, in platelets (which are confined to the vascular system), and in the central nervous system (4, 44) . Our peritoneal cell preparations contained 10 to 20% mast cells as identified by metachromatic staining; T cells, B cells, leucocytes, and macrophages were also present, but they are known to be generally serotonin nonproducers. Nevertheless, we cannot rule out the possibility that other peritoneal cells reacted to SEB and influenced the response of peritoneal mast cells.
The mechanism whereby SEB causes toxicosis is unknown. SEB has been called a "superantigen" because of its ability to stimulate murine and human T cells expressing particular VP variable elements of the antigen receptor, regardless of the Va elements (5, 18, 24, 53) . Marrack and coworkers (32) have found that weight loss and immunosuppression in SEB-injected mice is mediated through T cells that are capable of responding to SEB by dividing. Presumably, these T cells release various lymphokines, which in large quantities are toxic to a variety of cells. However, there is evidence that toxicity and T-cell mitogenicity are not necessarily associated with one another. For example, reduction of the disulfide loop of staphylococcal enterotoxin A (36) or toxoiding SEB with formaldehyde (45) does not completely destroy mitogenic activity but abolishes emetic activity. Furthermore, Spero and Morlock (46) showed that for SEC1, toxic and mitogenic activities are contained on different fragments of the molecule. Although the role of tumor necrosis factor alpha in enterotoxicosis is not known, it is of interest that Grossman and colleagues (14) abolished mitogenic activity of SEA and SEB by complete reduction and alkylation of the disulfide loops but that class IImediated stimulation of tumor necrosis factor alpha production by monocytes was not affected.
Scheuber and coworkers (41) proposed that SEB acts as a nonimmunological mast cell stimulator. They reported that intradermal injection of SEB in monkeys gives an immediate-type skin reaction (42) . This skin reaction, which is manifested by mast cell degranulation, is inhibited by H2 blockers of histamine, as is emesis. Hi blockers and an inhibitor of cysteinyl leukotrienes inhibit only the skin reaction. In addition, Jett and coworkers (23) found an increase in the levels of some products of the arachidonic acid cascade in monkeys challenged with SEB. All of these results suggest that mediators released by mast cells play an important role in SEB toxicosis.
The present work supports the idea that SEB can act on mast cells directly to release mediators and that SEB toxicosis involves various cell types. It is well known that mast cells can release a variety of mediators of inflammation and shock (for a review, see reference 15). In addition, it has been shown recently that both mouse peritoneal mast cells (13) and RBL-2H3 cells (37) produce tumor necrosis factor. This is interesting because SEB-induced shock resembles endotoxic shock (8) . On the other hand, there is good evidence that T-cell responses can produce some symptoms of SEB intoxication (32 antigen. This finding is consistent with the reports of other workers that enterotoxins also bind to non-MHC receptors (7, 19 In a variety of inflammatory reactions, bradykinin is produced by the activation of the kinin system. In the kinin system, bradykinin is produced from high-molecular-weight kininogen by the catalytic action of kallikrein (16) . Bradykinin is a powerful vasodilator; it causes increases of vascular permeability and smooth muscle contraction. Although it is not known whether bradykinin is produced during SEB toxicosis, the finding that bradykinin enhances mast cells to release serotonin is very interesting and requires further studies.
